Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC...

Prof Andrea Filippi - University of Pavia, Pavia, Italy

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )

Promise of personalised medicine for patients with prostate cancer

Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt...

Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )

Long term response to apalutamide and other updates impacting patients with...

Prof Axel Merseburger and Prof Matthew Smith

Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )

mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early...

Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt...

mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )

Diagnosis, testing and biomarkers in the individualisation of patient care with...

Prof Andrea Necchi and Prof Eva Compérat

Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bladder cancer ( Prof Andrea Necchi and Prof Eva Compérat )

Neo-adjuvant therapy and surgical decision making in breast cancer

Dr Mehra Golshan - Yale School of Medicine, New Haven, USA

Neo-adjuvant therapy and surgical decision making in breast cancer ( Dr Mehra Golshan - Yale School of Medicine, New Haven, USA )

Nurse's perspective on PARP inhibitors and personalised medicine in prostate...

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK

Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )

COVID-19 pandemic threatens global life-saving gains in childhood cancer

Prof Kathy Pritchard-Jones - University College London, London, UK

COVID-19 pandemic threatens global life-saving gains in childhood cancer ( Prof Kathy Pritchard-Jones - University College London, London, UK )

Emergence of PARP inhibitors in prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals...

Emergence of PARP inhibitors in prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with...

Dr Joshua Bauml and Dr Joshua Sabari

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC ( Dr Joshua Bauml and Dr Joshua Sabari )

New data from rare EGFR alterations in NSCLC from WCLC 2020

Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong

New data from rare EGFR alterations in NSCLC from WCLC 2020 ( Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong )

More from ecancer